Re: Serum vascular endothelial growth factor levels following luteal gonadotrophin‐releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome

Publisher： John Wiley & Sons Inc

E-ISSN： 1471-0528|122|4|585-585

ISSN： 1470-0328

Source： BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol.122, Iss.4, 2015-03, pp. : 585-585

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Authors’ reply re: Serum vascular endothelial growth factor levels following luteal gonadotrophin‐releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 4, 2015-03 ,pp. : 585-586

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 51, Iss. 1, 2018-01 ,pp. : 126-133

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 1, 2018-01 ,pp. : 95-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated Levels of Serum Vascular Endothelial Growth Factor in Patients with Polycythaemia vera

By  

Acta Haematologica, Vol. 110, Iss. 1, 2003-09 ,pp. : 16-19

Karger

Access to resources Recommend Favorite

Serum Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Levels Are Related in Patients with Polycythaemia vera

By  

Acta Haematologica, Vol. 112, Iss. 3, 2004-09 ,pp. : 170-171

Karger

Access to resources Recommend Favorite